7. [IF=4.212] Yingkun Sheng et al."PARP-1 inhibitor alleviates liver lipid accumulation of atherosclerosis via modulating bile acid metabolism and gut microbes."Molecular Omics.2023 May;: 6. Rong, Qian, et al. "In vitro and in vivo bactericidal activity of Tinospora sagittata (Oliv.) Gagnep. var. craveniana (SY Hu) Lo and its main effective component, palmatine, against porcine Helicobacter pylori." BMC complementary and alternative medicine 1 5. Yao, Ye, et al. "Berberine alleviates type 2 diabetic symptoms by altering gut microbiota and reducing aromatic amino acids." Biomedicine & Pharmacotherapy 131 (2020): 110669.https://doi.org/10.1016/j.biopha.2020.110669 4. Wan, Mimi, et al. "In situ growth of mesoporous silica with drugs on titanium surface and its biomedical applications."?ACS applied materials & interfaces?9.22 (2017): 18609-18618.https://doi.org/10.1021/acsami.7b05163 3. Zhe Hao, Xiaodong Lin, Jinjie Li, Yanliang Yin, Xia Gao, Shuo Wang, Yaqing Liu, Multifunctional nanoplatform for dual-mode sensitive detection of pathogenic bacteria and the real-time bacteria inactivation, Biosensors and Bioelectronics, Volume 173, 2021, 2. 吳芹, 許子洋, 劉麗萍,等. 腸道菌群在應激誘發大鼠高血壓中的作用[J]. 生物技術通報, 2020, v.36;No.331(02):88-95. 1. 王敏. 萬古霉素血藥濃度監測對臨床用藥指導意義的分析[J]. 臨床醫學研究與實踐 2020 v.5(16):114-116.